 | Up a level |
Wapp, Christina; Mittaz Hager, Anne-Gabrielle; Rikkonen, Toni; Hilfiker, Roger; Biver, Emmanuel; Ferrari, Serge; Kröger, Heikki; Zwahlen, Marcel; Zysset, Philippe (2024). Validation of a fall rate prediction model for community-dwelling older adults: a combined analysis of three cohorts with 1850 participants. BMC Geriatrics, 24, p. 287. BioMed Central 10.1186/s12877-024-04811-x
Vandenput, Liesbeth; Johansson, Helena; McCloskey, Eugene V; Liu, Enwu; Schini, Marian; Åkesson, Kristina E; Anderson, Fred A; Azagra, Rafael; Bager, Cecilie L; Beaudart, Charlotte; Bischoff-Ferrari, Heike A; Biver, Emmanuel; Bruyère, Olivier; Cauley, Jane A; Center, Jacqueline R; Chapurlat, Roland; Christiansen, Claus; Cooper, Cyrus; Crandall, Carolyn J; Cummings, Steven R; ... (2024). A meta-analysis of previous falls and subsequent fracture risk in cohort studies. Osteoporosis international, 35(3), pp. 469-494. Springer 10.1007/s00198-023-07012-1
Wapp, Christina; Biver, Emmanuel; Ferrari, Serge; Zysset, Philippe; Zwahlen, Marcel (2023). Development of a personalized fall rate prediction model in community-dwelling older adults: a negative binomial regression modelling approach. BMC Geriatrics, 23(1), p. 200. BioMed Central 10.1186/s12877-023-03922-1
Dudle, Alice; Gugler, Yvan; Pretterklieber, Michael; Ferrari, Serge; Lippuner, Kurt; Zysset, Philippe (2023). 2D-3D reconstruction of the proximal femur from DXA scans: Evaluation of the 3D-Shaper software. Frontiers in Bioengineering and Biotechnology, 11, p. 1111020. Frontiers Media 10.3389/fbioe.2023.1111020
Ferrari, Serge; Lippuner, Kurt; Lamy, Olivier; Meier, Christian (2020). 2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO). Swiss medical weekly, 150(w20352), w20352. EMH Media 10.4414/smw.2020.20352
Cosman, Felicia; Crittenden, Daria B; Ferrari, Serge; Khan, Aliya; Lane, Nancy E; Lippuner, Kurt; Matsumoto, Toshio; Milmont, Cassandra E; Libanati, Cesar; Grauer, Andreas (2018). FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab. Journal of bone and mineral research, 33(7), pp. 1219-1226. Wiley-Blackwell 10.1002/jbmr.3427
Meier, Christian; Uebelhart, Brigitte; Aubry-Rozier, Bérengère; Birkhäuser, Martin; Bischoff-Ferrari, Heike A; Frey, Diana; Kressig, Reto W; Lamy, Olivier; Lippuner, Kurt; Stute, Petra; Suhm, Norbert; Ferrari, Serge (2017). Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO. Swiss medical weekly, 147(w14484), w14484. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14484
